Frankfurt - Delayed Quote EUR
Takara Bio Inc. (TF2.F)
4.8200
+0.1400
+(2.99%)
As of 8:01:24 AM GMT+2. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
43,505,000
43,505,000
78,142,000
67,699,000
46,086,000
Cost of Revenue
16,597,000
16,597,000
33,377,000
18,488,000
14,214,000
Gross Profit
26,908,000
26,908,000
44,765,000
49,211,000
31,872,000
Operating Expense
23,904,000
23,904,000
24,219,000
20,307,000
17,917,000
Operating Income
3,004,000
3,004,000
20,546,000
28,904,000
13,955,000
Net Non Operating Interest Income Expense
163,000
163,000
118,000
99,000
89,000
Pretax Income
2,853,000
2,853,000
21,224,000
27,532,000
13,552,000
Tax Provision
1,343,000
1,343,000
5,176,000
7,624,000
3,971,000
Net Income Common Stockholders
1,480,000
1,480,000
16,012,000
19,849,000
9,547,000
Diluted NI Available to Com Stockholders
1,480,000
1,480,000
16,012,000
19,849,000
9,547,000
Basic EPS
12.30
--
132.97
164.84
79.29
Diluted EPS
12.30
--
132.97
164.84
79.29
Basic Average Shares
120,415
--
120,415
120,415
120,415
Diluted Average Shares
120,415.6000
--
120,415
120,415
120,415
Total Operating Income as Reported
3,003,000
3,003,000
20,541,000
28,902,000
13,952,000
Total Expenses
40,501,000
40,501,000
57,596,000
38,795,000
32,131,000
Net Income from Continuing & Discontinued Operation
1,480,000
1,480,000
16,012,000
19,849,000
9,547,000
Normalized Income
1,903,168
1,903,168
15,602,248
20,517,775
9,975,430.1948
Interest Income
186,000
186,000
142,000
122,000
113,000
Interest Expense
23,000
23,000
24,000
23,000
24,000
Net Interest Income
163,000
163,000
118,000
99,000
89,000
EBIT
2,876,000
2,876,000
21,248,000
27,555,000
13,576,000
EBITDA
7,897,000
7,897,000
25,983,000
31,704,000
17,362,000
Reconciled Cost of Revenue
16,597,000
16,597,000
33,377,000
18,488,000
14,214,000
Reconciled Depreciation
5,021,000
5,021,000
4,735,000
4,149,000
3,786,000
Net Income from Continuing Operation Net Minority Interest
1,480,000
1,480,000
16,012,000
19,849,000
9,547,000
Total Unusual Items Excluding Goodwill
-551,000
-551,000
542,000
-925,000
-606,000
Total Unusual Items
-551,000
-551,000
542,000
-925,000
-606,000
Normalized EBITDA
8,448,000
8,448,000
25,441,000
32,629,000
17,968,000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
-127,832
-127,832
132,248
-256,225
-177,569.8052
3/31/2021 - 12/16/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade